BioCentury
ARTICLE | Company News

Antitope, Cantab Biopharmaceuticals deal

March 29, 2010 7:00 AM UTC

Antitope will generate a high-yielding manufacturing mammalian cell line to develop a "biosuperior" protein therapeutic for a hematologic indication for Cantab. Further terms were not disclosed. ...